Back to VA VANGUARD CAPITAL MANAGEMENT LLC
BNTC2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in BENITEC BIOPHARMA INC
Yes. Vanguard Capital Management holds 954,533 shares of BNTC (Benitec Biopharma), worth $12.8M, as of its Q2 2026 13F filing. It increased the position by 22,977 shares (+2.5%) from Q1 2026. Vanguard Capital Management has held BNTC in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$12.8M
Current Shares
954,533
Total Value Change
+$2.9M
Total Shares Change
+22,977
Quarter-by-Quarter History
Other major holders of BNTC: Janus Henderson Group Ltd., FRANKLIN TEMPLETON INC